This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Aug;12(3):89.

doi: 10.1136/ebmh.12.3.89.

No significant difference between olanzapine and placebo for improvement in borderline personality disorder symptoms

Michela Nosè¹

Affiliations

PMID: 19633257
DOI: 10.1136/ebmh.12.3.89

Comment

No significant difference between olanzapine and placebo for improvement in borderline personality disorder symptoms

Michela Nosè. Evid Based Ment Health. 2009 Aug.

. 2009 Aug;12(3):89.

doi: 10.1136/ebmh.12.3.89.

Author

Michela Nosè¹

Affiliation

¹ Department of Medicine and Public Health, Section of Psychiatry, University of Verona, Italy.

PMID: 19633257
DOI: 10.1136/ebmh.12.3.89

No abstract available

PubMed Disclaimer

Comment on

Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study.
Schulz SC, Zanarini MC, Bateman A, Bohus M, Detke HC, Trzaskoma Q, Tanaka Y, Lin D, Deberdt W, Corya S. Schulz SC, et al. Br J Psychiatry. 2008 Dec;193(6):485-92. doi: 10.1192/bjp.bp.107.037903. Br J Psychiatry. 2008. PMID: 19043153 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.